Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet

Shares of Regenxbio (RGNX) have gained 9.3% over the past four weeks to close the last trading session at $8.21, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$35.55 indicates a potential upside of 333%.The average comprises 11 short-term price targets ranging from a low of $22 to a high of$52, with a standard deviation of $10.42. While the lowest estimate indicates an increa ...